|
2025
|
Invention
|
Amorphous (a-polymorphic) psilocybin.
Disclosed herein are compositions comprising amorphous psi... |
|
2024
|
Invention
|
Ergoline-derived agonists of the 5-ht2a receptor.
Provided herein are novel lisuride compounds, ... |
|
2023
|
Invention
|
5-ht2a and/or 5-ht2c receptor agonists.
Provided herein are heterocyclic compounds, processes fo... |
|
|
Invention
|
5-ht receptor agonist titration.
Disclosed herein are methods of treating neuropsychiatric and c... |
|
|
Invention
|
Amorphous (a-polymorphic) psilocybin |
|
|
Invention
|
Amorphous (a-polymorphic) psilocybin. Disclosed herein are compositions comprising amorphous psil... |
|
|
Invention
|
Pre-dosing method of assessing drug benefits in patients.
Disclosed herein are methods of treatm... |
|
|
Invention
|
Pre-dosing method of assessing drug benefits in patients. Disclosed herein are methods of treatme... |
|
|
Invention
|
Extended release 5-ht receptor agonists for neurological conditions.
Disclosed herein are compos... |
|
2022
|
Invention
|
Compositions and methods for managing disorders.
Disclosed herein are methods for managing disor... |
|
|
Invention
|
Ergoline-derived agonists of the 5-ht2a receptor. Provided herein are novel lisuride compounds, p... |
|
|
Invention
|
Systems and methods for affecting well-being.
Disclosed herein are systems and methods for affec... |
|
|
Invention
|
Systems and methods for affecting well-being. Disclosed herein are systems and methods for affect... |
|
|
Invention
|
5-ht2a and/or 5-ht2c receptor agonists. Provided herein are heterocyclic compounds, processes for... |
|
|
Invention
|
5-ht receptor agonist titration. Disclosed herein are methods of treating neuropsychiatric and co... |
|
|
P/S
|
Custom manufacture for others of psychedelic-based pharmaceuticals, pharmaceutical drugs, therape... |
|
|
P/S
|
Custom manufacture for others of pharmaceuticals, pharmaceutical drugs, pharmaceutical preparatio... |
|
2021
|
P/S
|
Pharmaceutical preparations; pharmaceutical products; pharmaceutical preparations for the treatme... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of central nervous system [CNS] diseases and mental... |
|
|
Invention
|
Extended release 5-ht receptor agonists for neurological conditions. Provided herein are methods ... |
|
2020
|
Invention
|
Methods and compositions comprising a 5ht receptor agonist for the treatment of psychological, co... |
